期刊
CANCER LETTERS
卷 299, 期 2, 页码 130-136出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2010.08.011
关键词
Vascular endothelial growth factor; Osteopontin; Tumor; Angiogenesis; Metastasis
类别
资金
- National Natural Science Foundation of China
- Ministry of Science & Technology of China
- National Key Project for Infectious Diseases
- National Key project for New Drug Development and Manufacture
- Beijing and Shanghai Commission of Science Technology
- Ministry of Education of China
- Shanghai Commission of Education for excellent research team in Oncology
- Shanghai Key Project in Oncology
- Shanghai Rising-Star Program
- Dongfang Scholar
Both vascular endothelial growth factor A (VEGF) and osteopontin (OPN) can directly induce tumor angiogenesis, which is essential for the growth and metastasis of solid tumors. Here we engineered a bispecific antibody (VEGF/OPN-BsAb) using the anti-VEGF-A antibody bevacizumab and the anti-OPN antibody hu1A12. Compared with hu1Al2 alone and bevacizumab alone, VEGF/OPN-BsAb was significantly more effective in inhibiting tumor angiogenesis in a highly metastatic human hepatocellular carcinoma nude mouse model. Further study demonstrated that VEGF/OPN-BsAb could effectively suppress primary tumor growth and metastasis to lungs, suggesting that it might be a promising therapeutic agent for treatment of metastatic cancer. (c) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据